HEALTH ECONOMICS OF PHARMACOGENETIC TESTING
Ph.D
Saved in:
Main Author: | DONG DI |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/121862 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
Pharmacogenetics of Warfarin Should we test?
by: Pantep Angchaisuksiri, et al.
Published: (2022) -
Pharmacogenetics: Role in modifying drug dosage regimens
by: Mah, J.T.L., et al.
Published: (2014) -
The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing
by: Chan, S.L., et al.
Published: (2014) -
Clinical pharmacology and pharmacogenetics of gemcitabine
by: Wong, A., et al.
Published: (2014) -
Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public
by: Chan, S.L., et al.
Published: (2014)